An investigational therapeutic vaccine showed clinical effectiveness in patients with human papillomavirus (HPV)16-positive cervical intraepithelial neoplasia grade 3 (CIN3), according to results ...
"Nearly all premalignant cervical lesions and cervical cancers ... In those with grade 3 cervical intraepithelial neoplasia (CIN3), cells are already on the path toward malignancy.
A large majority of high-grade lesions in the female genital ... the vaccine was 100% effective in preventing cervical intraepithelial neoplasia (CIN)1-3 and adenocarcinoma in situ (AIS ...